Mark S Forman is CHIEF MEDICAL OFFICER of Passage BIO, Inc.. Currently has a direct ownership of 48,631 shares of PASG, which is worth approximately $33,069. The most recent transaction as insider was on Feb 13, 2024, when has been sold 1,638 shares (Common Stock) at a price of $0.97 per share, resulting in proceeds of $1,588. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48.6K
0% 3M change
n/a 12M change
Total Value Held $33,069

Mark S Forman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 13 2024
SELL
Open market or private sale
$1,588 $0.97 p/Share
1,638 Reduced 3.26%
48,631 Common Stock
Feb 10 2024
BUY
Exercise of conversion of derivative security
-
5,000 Added 9.05%
50,269 Common Stock
Jan 02 2024
SELL
Open market or private sale
$14,389 $0.91 p/Share
15,813 Reduced 25.89%
45,269 Common Stock
Dec 31 2023
BUY
Exercise of conversion of derivative security
-
50,000 Added 45.01%
61,082 Common Stock

Also insider at

VTYX
Ventyx Biosciences, Inc. Healthcare
MSF

Mark S Forman

CHIEF MEDICAL OFFICER
Philadelphia, PA

Track Institutional and Insider Activities on PASG

Follow Passage BIO, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PASG shares.

Notify only if

Insider Trading

Get notified when an Passage Bio, Inc. insider buys or sells PASG shares.

Notify only if

News

Receive news related to Passage BIO, Inc.

Track Activities on PASG